Elaia is a Paris-headquartered venture firm founded in 2002 that invests in deep tech and B2B digital companies, with additional offices in Barcelona and Tel Aviv. It closed its third DeepTech Seed fund (DTS3) at €134M, investing at pre-seed and seed with tickets from €1M up to €13M including follow-ons, across computing, AI, semiconductors and photonics, quantum, robotics, new materials, energy, biotech and digital health. The firm sources a large share of deals through partnerships with European research institutions. Its site reports around €850M under management, roughly 100 investments and 80 exits, including Mirakl, Shift Technology, Alice&Bob, Aqemia, SeqOne and iBanFirst.
Investment thesis
Elaia is a European venture capital firm with roughly 850 million euros under management and offices in Paris, Barcelona and Tel Aviv. It invests from seed onwards and follows companies through to market leadership, with about 100 investments, 80 exits and three seed-to-unicorn outcomes recorded. It states that it partners with entrepreneurs from inception to leadership, helping them navigate the future and the unknown.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Relaisanté France | Series A | Sep 2026 | €6M |
| Kheops France | Growth | Sep 2026 | €12M |
| Mimic Switzerland | Seed | Nov 2025 | €13.8M |
| Primaa France | Series A | Oct 2025 | €7M |
| iBanFirst Brussels, Belgium | Series C | Jun 2020 | €21M |
| Aqemia Paris, France | Pre-seed | Oct 2019 | €1M |
| SeqOne Montpellier, France | Seed | Mar 2019 | €3M |
| Teads Luxembourg | Series A | Oct 2013 | €3.8M |
| Mirakl Paris, France | Seed | Nov 2012 | €2.5M |